Sichuan Hebang Biotechnology 和邦生物
22 significant filings since 31 May 2026: 3 on share pledge, 5 on major holder selling and 4 on buyback, and 5 other kinds. The latest, on 11 Sep 2026: 和邦生物关于控股股东部分股份解除质押及部分股份质押的公告. On 14 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 614.68% to 730.57% from the same period a year earlier.
自 31 May 2026 起有 22 份重大公告：share pledge 3 份、major holder selling 5 份、buyback 4 份，另有 5 类。最新一份（11 Sep 2026）：和邦生物关于控股股东部分股份解除质押及部分股份质押的公告。14 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 614.68% 至 730.57%。
Price History 价格走势
250 trading days 个交易日 · High 最高 ¥3.33 · Low 最低 ¥1.91| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥191亿 | ¥64亿 | 9th highest of 62 · 62 家中第 9 高 | |
| Trailing P/E 市盈率 | — | 19.3x | No value 无数据 | |
| P/B 市净率 | 1.0x | 1.8x | 8th lowest of 62 · 62 家中第 8 低 | |
| Revenue Growth 营收增速 | -26.3% | 6.9% | 2nd lowest of 62 · 62 家中第 2 低 | |
| Profit Growth 净利增速 | 634.3% | 1.9% | 2nd highest of 62 · 62 家中第 2 高 | |
| Gross Margin 毛利率 | 28.9% | 19.1% | 14th highest of 62 · 62 家中第 14 高 | |
| Net Margin 净利率 | 13.0% | 6.2% | 13th highest of 62 · 62 家中第 13 高 | |
| Return on Equity 净资产收益率 | 2.1% | 3.5% | 21st lowest of 62 · 62 家中第 21 低 | |
| Debt to Assets 资产负债率 | 34.7% | 41.2% | 18th lowest of 62 · 62 家中第 18 低 | |
| Grade Score 评级得分 | 52 | 50 | 28th highest of 62 · 62 家中第 28 高 |
Statement figures are for the period to 30 Jun 2026, filed by 62 of 62 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，62 家同业中 62 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Qinghai Salt Lake 盐湖股份 | ¥1,224亿 | 10.2x | 2.6x | 79.9% | 55.5% | 13.3% | A |
| Zangge Mining 藏格矿业 | ¥1,097亿 | 19.3x | 6.4x | 23.0% | 175.8% | 21.2% | B |
| Shandong Hualu-Hengsheng Chemical 华鲁恒升 | ¥533亿 | 13.0x | 1.2x | 8.9% | 14.8% | 6.9% | C |
| Yunnan Yuntianhua 云天化 | ¥495亿 | 9.3x | 1.9x | -8.9% | 13.7% | 11.4% | C |
| Asia-Potash International Investment 亚钾国际 | ¥335亿 | 15.5x | 2.3x | 51.5% | 35.4% | 9.6% | B |
| Xingfa Group 兴发集团 | ¥324亿 | 20.2x | 1.3x | 19.4% | 5.7% | 3.5% | D |
| Hongda 宏达股份 | ¥311亿 | — | 9.9x | -4.3% | -1.4% | -0.8% | D |
| Yangnong Chemical 扬农化工 | ¥208亿 | 16.3x | 1.7x | 6.0% | 12.0% | 6.7% | C |
| Sichuan Hebang Biotechnology 和邦生物 | ¥191亿 | — | 1.0x | -26.3% | 13.0% | 2.1% | C |
| Guizhou Chanhen Chemical 川恒股份 | ¥182亿 | 14.2x | 2.5x | 20.8% | 15.1% | 7.1% | C |
| Shandong Weifang Rainbow Chemical 润丰股份 | ¥178亿 | 17.9x | 2.3x | 13.9% | 7.7% | 6.5% | C |
| Qingdao East Steel Tower Stock 东方铁塔 | ¥172亿 | 10.2x | 1.7x | 42.0% | 32.0% | 9.5% | B |
| Yonfer Agricultural Technology 新洋丰 | ¥171亿 | 10.5x | 1.4x | 20.0% | 8.8% | 7.8% | C |
| Sichuan Development Lomon 川发龙蟒 | ¥153亿 | 38.2x | 1.6x | 14.8% | 4.5% | 2.3% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。